The impact of managed care systems on relapse prevention and quality of life for patients with schizophrenia
- 31 December 1996
- journal article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 6, 35-39
- https://doi.org/10.1016/0924-977x(96)00009-0
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Efficacy and safety of risperidone in the long-term treatment of patients with schizophreniaClinical Therapeutics, 1995
- Long-term outcome of state hospital patients discharged into structured community residential settingsPsychiatric Services, 1995
- Effects of Limiting Medicaid Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with SchizophreniaNew England Journal of Medicine, 1994
- Cost effectiveness of clozapine in neuroleptic-resistant schizophreniaAmerican Journal of Psychiatry, 1993
- Evaluating quality-of-life measures for clinical trials in GermanyControlled Clinical Trials, 1991
- Overview: maintenance therapy in psychiatry: I. SchizophreniaAmerican Journal of Psychiatry, 1975